Monday, March 1, 2021

Opinion Today: On the borderlands of life

A Q&A with the science writer Carl Zimmer.
Author Headshot

By Aaron Retica

Editor at Large, Opinion

I met Carl Zimmer in a small college library many years ago. It will give you a hint of how old we are that smoking was allowed, almost encouraged. (Ashtrays!) Carl and I were among a tiny minority that did not smoke but worked there anyway. When you're 18, you are stupid about a lot of things; we were stupid about secondhand smoke.

I mostly edit pieces on politics, sociology and history, but I also like to edit stories about science and animals whenever I can, with writers like Frans de Waal, Alexandra Horowitz, Maria Konnikova and Jon Mooallem. Yet somehow I had never worked with Carl, the science columnist for The Times, before plunging into his Sunday Review cover story about where viruses fall on the continuum between animate and inanimate, which ends by showing us that "if viruses are lifeless … lifelessness is stitched into our very being."

I asked Carl a few questions about what it's like to be writing at the intersection of science and society during these perilous days.

AR: When we were in college, it felt like the genetic revolution was underway. But what was happening then now seems incredibly primitive. How have you adjusted to writing about science as it has gotten more and more sophisticated?

ADVERTISEMENT

CZ: When we met, the idea of reading all your DNA — your genome — was an absurd fantasy. Now you can get your own genome sequenced for a few hundred bucks.

Sequencing genes has completely changed biology. We're learning not just about ourselves, but about all living things, including viruses. Right now, our best hope of crushing the pandemic is sequencing thousands of genomes of coronaviruses every day to search for new variants that are more contagious or can evade vaccines.

I still get press releases announcing the first genome sequenced from yet another species — redwoods, octopuses and so on. So I guess I'm jaded now. I'm not thrilled by the mere idea that scientists can sequence a genome anymore. Now I want to hear about what scientists have discovered in that genome.

AR: Pursuing the intellectual and scientific stories surrounding the pandemic can sometimes feel a little weird, almost incongruous. How do you reconcile your interest in what lies behind the science and the tragedy in front of you?

ADVERTISEMENT

CZ: We've always dealt with the tragedy of epidemics, not to mention the steady toll taken by diseases like malaria and tuberculosis. What's different now is that we are learning about the causes of those diseases, down to the molecular details. The fact that viruses straddle the boundary of life and death is important to understand for practical reasons. For instance, we can understand how long they can remain infectious even when they're frozen or crystallized — challenges that would kill ordinary life-forms. Learning how viruses have evolved over huge time spans can tell us a lot about how they may evolve in the future — and how to stop them from overcoming our vaccines and antivirals.

But it's true that virologists can have a strange fascination with these deadly pathogens. Recently a virologist at the University of Pittsburgh named Paul Duprex was telling me about the elegant ways by which coronavirus variants are evolving their way around our immune systems. They're changing the shape of their proteins so that antibodies can't stick to them, while not losing their ability to replicate in our cells. "It's so cool, it is absolutely brilliant!" he said, almost in admiration. "That's why I love the damn things."

AR: Your essay in Sunday Review draws on a book you are publishing soon about the space between being alive and … not being alive. Besides viruses, what are some other interesting examples of creatures that exist in the liminal space between animate and inanimate?

CZ: I've always been fascinated by the fact that biologists spend their careers studying life and yet they can't agree on what life is. For "Life's Edge," I took a number of trips to encounter life as we know it, and as we don't. On the borderlands of life, I got to know not just viruses, but other strange things, such as pea-sized clusters of human brain cells that develop like baby brains and drops of inert chemicals that race around Petri dishes like frantic cheetahs. It's hard to know what to make of these things, which is why they're so important to coming up with a full understanding of life.

ADVERTISEMENT

Here's what we're focusing on today:

Ideas

Why Is China Still Going After Hong Kong So Hard?

The president may be putting personal ambition ahead of his country's best interests.

By Yi-Zheng Lian

Article Image

If Government Did Its Job We Might Not Need GoFundMe

The crowdfunding platform helps people pay their rent and medical bills. Its chief executive, Tim Cadogan, says it was never meant to be a social safety net.

By Kara Swisher

Article Image

The Private Equity Party Might Be Ending. It's About Time.

A recent legal decision may force Wall Street to think twice before saddling struggling companies with debts they can't handle.

By William D. Cohan

Article Image

My 6 Months as a Solo Parent

After my wife was deployed, I found myself caring for four kids on my own — something my mother did for my whole childhood.

By Esau McCaulley

Article Image

I Will Not Rest Until This Garden Grows

Letting nature take its course is getting harder to do.

By Margaret Renkl

Article Image

Forward this newsletter to friends to share ideas and perspectives that will help inform their lives. They can sign up here. Do you have feedback? Email us at opiniontoday@nytimes.com

Contact Us
If you have questions about your Times account, delivery problems or other issues, visit our Help Page or contact The Times.

Need help? Review our newsletter help page or contact us for assistance.

David Leonhardt's newsletter is now the Opinion Today newsletter. You received this email because you signed up for David Leonhardt's newsletter or the Opinion Today newsletter from The New York Times.

To stop receiving these emails, unsubscribe or manage your email preferences.

Subscribe to The Times

Connect with us on:

facebooktwitterinstagram

Change Your EmailPrivacy PolicyContact UsCalifornia Notices

The New York Times Company. 620 Eighth Avenue New York, NY 10018

No comments:

Post a Comment